{"nctId":"NCT02197481","briefTitle":"Usefulness of BiClamp Forceps for Liver Resection: A Randomized Clinical Trial","startDateStruct":{"date":"2014-09"},"conditions":["Hepatobiliary Disease"],"count":105,"armGroups":[{"label":"Clamp-Crushing technique","type":"ACTIVE_COMPARATOR","interventionNames":["Procedure: Clamp-Crushing technique"]},{"label":"BiClamp forceps hepatectomy","type":"EXPERIMENTAL","interventionNames":["Device: BiClamp forceps"]}],"interventions":[{"name":"Clamp-Crushing technique","otherNames":[]},{"name":"BiClamp forceps","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Both male and female, aged 18 or older\n* Patients scheduled to undergo hepatic resection for some benign or malignant hepatobiliary disease\n* Child-Pugh class A or B liver function\n* BiClamp forceps hepatectomy and clamp-crushing feasible based on preoperative imaging\n* No tumor invasion the main vein, hepatic artery and vein and major inferior vena cava\n* No extrahepatic metastasis\n* Voluntary participation in the study, and informed consent.\n\nExclusion Criteria:\n\n* Age \\<18 years or\\> 65 years , pregnant or lactating women\n* Preoperative liver function evaluation: Child-Pugh C grade\n* Laparoscopic hepatectomy\n* Extrahepatic metastasis\n* Tumor invasion the main vein, hepatic artery and vein and major inferior vena cava\n* The patient refused to sign the informed consent form","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"The Total Blood Loss","description":"Blood loss during operation. Blood loss was calculated from the beginning to the end of operation The amount of blood loss was measured from the suction volume after subtraction of rinse fluids and from the weight of soaked gauzes that were used during transection","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"376.73","spread":"303.67"},{"groupId":"OG001","value":"339.81","spread":"257.20"}]}]}]},{"type":"SECONDARY","title":"Liver Transection Time","description":"liver transection time was calculated from the beginning to the end of the liver resection","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"25.51","spread":"12.19"},{"groupId":"OG001","value":"26.21","spread":"17.17"}]}]}]},{"type":"SECONDARY","title":"Mortality","description":"Operative mortality was defined as any death resulting from a complication during surgery","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Morbidity","description":null,"paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"13","spread":null},{"groupId":"OG001","value":"12","spread":null}]}]}]},{"type":"SECONDARY","title":"Biliary Leakage","description":"Biliary leakage was documented in line with the International Study Group of Liver Surgery (ISGLS) definitions and grading systems","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]}]},{"type":"SECONDARY","title":"Duration of Postoperative Hospital Stay","description":"Time from day of operation to day of discharge","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8.65","spread":"2.02"},{"groupId":"OG001","value":"8.81","spread":"2.49"}]}]}]},{"type":"SECONDARY","title":"Number of Participants Requiring a Blood Transfusion","description":"Administration of blood transfusions is documented for the intraoperative and postoperative period until 48 hours postoperatively","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"4","spread":null}]}]}]},{"type":"SECONDARY","title":"Total Bilirubin","description":"serum total bilirubin on 3 postoperative day (umol/L)","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"17.70","spread":"11.34"},{"groupId":"OG001","value":"18.46","spread":"17.75"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":4,"n":43},"commonTop":["pleural effusions","Liver failure","Wound infection","Biliary leakage"]}}}